Skip to main content
Published locations for Advanced TNBC: Camrelizumab + apatinib and eribulin shows promise in heavily pretreated patients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Advanced TNBC: Camrelizumab + apatinib and eribulin shows promise in heavily pretreated patients
User login
Username
Password
Reset your password
/content/advanced-tnbc-camrelizumab-apatinib-and-eribulin-shows-promise-heavily-pretreated-patients
/hematology-oncology/article/255686/breast-cancer/advanced-tnbc-camrelizumab-apatinib-and-eribulin
/breast-cancer-icymi/article/255686/breast-cancer/advanced-tnbc-camrelizumab-apatinib-and-eribulin